The distribution of Obesity Treatment Market Share is currently concentrated among a few major pharmaceutical players who have successfully navigated the rigorous clinical development and regulatory pathways for novel anti-obesity medications. Market share dominance is directly tied to the commercial success of blockbuster drugs, particularly those in the GLP-1 receptor agonist class, which...